Related Experiment Videos
Combined treatment of Parkinsonian tremor with propranolol and levodopa
Journal of the Neurological Sciences
|December 1, 1971
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Oral laquinimod in patients with relapsing-remitting multiple sclerosis: 36-week double-blind active extension of the multi-centre, randomized, double-blind, parallel-group placebo-controlled study.
Multiple sclerosis (Houndmills, Basingstoke, England)·2010
Randomized study of once-weekly interferon beta-1la therapy in relapsing multiple sclerosis: three-year data from the OWIMS study.
Multiple sclerosis (Houndmills, Basingstoke, England)·2005
Spindle imaging: a new marker for optimal timing of ICSI?
Human reproduction (Oxford, England)·2004
Antibodies to glatiramer acetate do not interfere with its biological functions and therapeutic efficacy.
Multiple sclerosis (Houndmills, Basingstoke, England)·2003
White matter hyperintensity burden is associated with neuroaxonal injury in acute ischemic stroke.
Journal of the neurological sciences·2026
Re-treatment of Guillain-Barré syndrome (GBS) in the post-SID-GBS trial era.
Journal of the neurological sciences·2026
Valproate use in low- and middle-income countries: Balancing reproductive safety, seizure control, and access to safer antiseizure medicines.
Journal of the neurological sciences·2026
Infections and the neuromuscular junction: From direct neurotoxicity to immune-mediated dysfunction.
Journal of the neurological sciences·2026
Reduction of interleukin-6 levels in patients with Friedreich's Ataxia treated with omaveloxolone.
Journal of the neurological sciences·2026
Aldosterone synthase inhibitors may alter how primary care treats hypertension.
American journal of hypertension·2026
The hypertension specialist's perspective: aldosterone synthase inhibitors to fill the gap in difficult-to-control and resistant hypertension.
American journal of hypertension·2026
From bench to formulary: a pharmacological appraisal of aldosterone synthase inhibitors for uncontrolled and resistant hypertension.
American journal of hypertension·2026